nodes	percent_of_prediction	percent_of_DWPC	metapath
Tetrabenazine—DRD2—nicotine dependence	0.831	1	CbGaD
Tetrabenazine—SLC18A2—Nicotine Activity on Dopaminergic Neurons—CHRNA6—nicotine dependence	0.0108	0.122	CbGpPWpGaD
Tetrabenazine—SLC18A2—Nicotine Activity on Dopaminergic Neurons—CHRNA5—nicotine dependence	0.00696	0.0788	CbGpPWpGaD
Tetrabenazine—Extrapyramidal symptoms—Varenicline—nicotine dependence	0.00627	0.0812	CcSEcCtD
Tetrabenazine—Balance disorder—Varenicline—nicotine dependence	0.00595	0.0771	CcSEcCtD
Tetrabenazine—SLC18A2—Nicotine Activity on Dopaminergic Neurons—CHRNA3—nicotine dependence	0.00568	0.0643	CbGpPWpGaD
Tetrabenazine—DRD2—Nicotine Activity on Dopaminergic Neurons—CHRNA6—nicotine dependence	0.00517	0.0586	CbGpPWpGaD
Tetrabenazine—SLC18A2—Nicotine Activity on Dopaminergic Neurons—CHRNB2—nicotine dependence	0.005	0.0566	CbGpPWpGaD
Tetrabenazine—SLC18A2—Nicotine Activity on Dopaminergic Neurons—CHRNA4—nicotine dependence	0.00454	0.0514	CbGpPWpGaD
Tetrabenazine—Extrapyramidal disorder—Varenicline—nicotine dependence	0.00432	0.056	CcSEcCtD
Tetrabenazine—SLC18A2—Nicotine Activity on Dopaminergic Neurons—DRD2—nicotine dependence	0.00369	0.0418	CbGpPWpGaD
Tetrabenazine—CYP2D6—CYP2E1 reactions—CYP2A7—nicotine dependence	0.00366	0.0414	CbGpPWpGaD
Tetrabenazine—Dysarthria—Varenicline—nicotine dependence	0.00344	0.0445	CcSEcCtD
Tetrabenazine—DRD2—Nicotine Activity on Dopaminergic Neurons—CHRNA5—nicotine dependence	0.00333	0.0377	CbGpPWpGaD
Tetrabenazine—Photophobia—Varenicline—nicotine dependence	0.00306	0.0396	CcSEcCtD
Tetrabenazine—CYP2D6—Fatty acids—CYP2A7—nicotine dependence	0.00286	0.0323	CbGpPWpGaD
Tetrabenazine—Sleep disorder—Varenicline—nicotine dependence	0.00273	0.0353	CcSEcCtD
Tetrabenazine—DRD2—Nicotine Activity on Dopaminergic Neurons—CHRNA3—nicotine dependence	0.00272	0.0308	CbGpPWpGaD
Tetrabenazine—Disorientation—Varenicline—nicotine dependence	0.00264	0.0342	CcSEcCtD
Tetrabenazine—DRD2—Nicotine Activity on Dopaminergic Neurons—CHRNB2—nicotine dependence	0.00239	0.0271	CbGpPWpGaD
Tetrabenazine—Osteoarthritis—Varenicline—nicotine dependence	0.00236	0.0306	CcSEcCtD
Tetrabenazine—CYP2D6—Xenobiotics—CYP2A7—nicotine dependence	0.00227	0.0257	CbGpPWpGaD
Tetrabenazine—Irritability—Varenicline—nicotine dependence	0.00226	0.0292	CcSEcCtD
Tetrabenazine—DRD2—Nicotine Activity on Dopaminergic Neurons—CHRNA4—nicotine dependence	0.00217	0.0246	CbGpPWpGaD
Tetrabenazine—Abdominal pain upper—Varenicline—nicotine dependence	0.00216	0.0279	CcSEcCtD
Tetrabenazine—Breast disorder—Varenicline—nicotine dependence	0.00214	0.0276	CcSEcCtD
Tetrabenazine—Dysphagia—Varenicline—nicotine dependence	0.00204	0.0264	CcSEcCtD
Tetrabenazine—Bronchitis—Varenicline—nicotine dependence	0.00196	0.0254	CcSEcCtD
Tetrabenazine—SLC18A2—Transmission across Chemical Synapses—CHRNB3—nicotine dependence	0.00188	0.0213	CbGpPWpGaD
Tetrabenazine—Depression—Varenicline—nicotine dependence	0.00182	0.0235	CcSEcCtD
Tetrabenazine—SLC18A2—Transmission across Chemical Synapses—CHRNA6—nicotine dependence	0.00178	0.0202	CbGpPWpGaD
Tetrabenazine—Bradycardia—Varenicline—nicotine dependence	0.00166	0.0215	CcSEcCtD
Tetrabenazine—Urinary tract disorder—Varenicline—nicotine dependence	0.00161	0.0209	CcSEcCtD
Tetrabenazine—Urethral disorder—Varenicline—nicotine dependence	0.0016	0.0207	CcSEcCtD
Tetrabenazine—Eye disorder—Varenicline—nicotine dependence	0.00153	0.0198	CcSEcCtD
Tetrabenazine—Cardiac disorder—Varenicline—nicotine dependence	0.00152	0.0196	CcSEcCtD
Tetrabenazine—Angiopathy—Varenicline—nicotine dependence	0.00148	0.0192	CcSEcCtD
Tetrabenazine—SLC18A2—Neuronal System—CHRNB3—nicotine dependence	0.00144	0.0163	CbGpPWpGaD
Tetrabenazine—Mental disorder—Varenicline—nicotine dependence	0.00143	0.0185	CcSEcCtD
Tetrabenazine—SLC18A2—Neuronal System—CHRNA6—nicotine dependence	0.00136	0.0154	CbGpPWpGaD
Tetrabenazine—Tremor—Varenicline—nicotine dependence	0.00133	0.0173	CcSEcCtD
Tetrabenazine—Agitation—Varenicline—nicotine dependence	0.00131	0.0169	CcSEcCtD
Tetrabenazine—SLC18A2—Transmission across Chemical Synapses—GABRA4—nicotine dependence	0.00129	0.0146	CbGpPWpGaD
Tetrabenazine—SLC18A2—Transmission across Chemical Synapses—CHRNB4—nicotine dependence	0.00123	0.014	CbGpPWpGaD
Tetrabenazine—Anxiety—Varenicline—nicotine dependence	0.00121	0.0156	CcSEcCtD
Tetrabenazine—Unspecified disorder of skin and subcutaneous tissue—Varenicline—nicotine dependence	0.0012	0.0156	CcSEcCtD
Tetrabenazine—Dry mouth—Varenicline—nicotine dependence	0.00118	0.0153	CcSEcCtD
Tetrabenazine—SLC18A2—Transmission across Chemical Synapses—CHRNA5—nicotine dependence	0.00115	0.013	CbGpPWpGaD
Tetrabenazine—Nervous system disorder—Varenicline—nicotine dependence	0.00114	0.0147	CcSEcCtD
Tetrabenazine—Skin disorder—Varenicline—nicotine dependence	0.00113	0.0146	CcSEcCtD
Tetrabenazine—Hyperhidrosis—Varenicline—nicotine dependence	0.00112	0.0145	CcSEcCtD
Tetrabenazine—Hypotension—Varenicline—nicotine dependence	0.00109	0.014	CcSEcCtD
Tetrabenazine—Insomnia—Varenicline—nicotine dependence	0.00105	0.0136	CcSEcCtD
Tetrabenazine—Dyspnoea—Varenicline—nicotine dependence	0.00104	0.0134	CcSEcCtD
Tetrabenazine—Somnolence—Varenicline—nicotine dependence	0.00103	0.0134	CcSEcCtD
Tetrabenazine—Decreased appetite—Varenicline—nicotine dependence	0.00101	0.0131	CcSEcCtD
Tetrabenazine—Fatigue—Varenicline—nicotine dependence	0.001	0.013	CcSEcCtD
Tetrabenazine—Constipation—Varenicline—nicotine dependence	0.000993	0.0129	CcSEcCtD
Tetrabenazine—SLC18A2—Neuronal System—GABRA4—nicotine dependence	0.000986	0.0112	CbGpPWpGaD
Tetrabenazine—Feeling abnormal—Varenicline—nicotine dependence	0.000957	0.0124	CcSEcCtD
Tetrabenazine—SLC18A2—Neuronal System—CHRNB4—nicotine dependence	0.000946	0.0107	CbGpPWpGaD
Tetrabenazine—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.000942	0.0107	CbGpPWpGaD
Tetrabenazine—SLC18A2—Transmission across Chemical Synapses—CHRNA3—nicotine dependence	0.000935	0.0106	CbGpPWpGaD
Tetrabenazine—CBR1—cardiovascular system—nicotine dependence	0.000935	0.243	CbGeAlD
Tetrabenazine—CYP2D6—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.000929	0.0105	CbGpPWpGaD
Tetrabenazine—Body temperature increased—Varenicline—nicotine dependence	0.000918	0.0119	CcSEcCtD
Tetrabenazine—SLC18A2—Neuronal System—CHRNA5—nicotine dependence	0.000879	0.00995	CbGpPWpGaD
Tetrabenazine—DRD2—G alpha (i) signalling events—TAS2R16—nicotine dependence	0.000841	0.00952	CbGpPWpGaD
Tetrabenazine—Asthenia—Varenicline—nicotine dependence	0.000833	0.0108	CcSEcCtD
Tetrabenazine—SLC18A2—Transmission across Chemical Synapses—CHRNB2—nicotine dependence	0.000824	0.00932	CbGpPWpGaD
Tetrabenazine—Diarrhoea—Varenicline—nicotine dependence	0.000795	0.0103	CcSEcCtD
Tetrabenazine—Dizziness—Varenicline—nicotine dependence	0.000768	0.00994	CcSEcCtD
Tetrabenazine—CYP2D6—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.000763	0.00864	CbGpPWpGaD
Tetrabenazine—SLC18A2—Transmission across Chemical Synapses—CHRNA4—nicotine dependence	0.000748	0.00846	CbGpPWpGaD
Tetrabenazine—Vomiting—Varenicline—nicotine dependence	0.000738	0.00956	CcSEcCtD
Tetrabenazine—CBR1—midbrain—nicotine dependence	0.00073	0.19	CbGeAlD
Tetrabenazine—Headache—Varenicline—nicotine dependence	0.000728	0.00942	CcSEcCtD
Tetrabenazine—SLC18A2—Neuronal System—CHRNA3—nicotine dependence	0.000717	0.00811	CbGpPWpGaD
Tetrabenazine—Nausea—Varenicline—nicotine dependence	0.00069	0.00893	CcSEcCtD
Tetrabenazine—SLC18A2—Neuronal System—CHRNB2—nicotine dependence	0.000631	0.00714	CbGpPWpGaD
Tetrabenazine—SLC18A2—midbrain—nicotine dependence	0.000628	0.163	CbGeAlD
Tetrabenazine—SLC18A2—Neuronal System—CHRNA4—nicotine dependence	0.000573	0.00649	CbGpPWpGaD
Tetrabenazine—CBR1—Metabolism—CYP2A7—nicotine dependence	0.000533	0.00604	CbGpPWpGaD
Tetrabenazine—SLC18A2—Transmembrane transport of small molecules—GABRA4—nicotine dependence	0.00053	0.006	CbGpPWpGaD
Tetrabenazine—DRD2—GPCR ligand binding—TAS2R16—nicotine dependence	0.000509	0.00576	CbGpPWpGaD
Tetrabenazine—CBR1—brain—nicotine dependence	0.000459	0.119	CbGeAlD
Tetrabenazine—CYP2D6—Metapathway biotransformation—AKR1B10—nicotine dependence	0.00043	0.00487	CbGpPWpGaD
Tetrabenazine—CYP2D6—Biological oxidations—CYP2A7—nicotine dependence	0.000406	0.00459	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metapathway biotransformation—CYP2A7—nicotine dependence	0.0004	0.00453	CbGpPWpGaD
Tetrabenazine—SLC18A2—brain—nicotine dependence	0.000394	0.103	CbGeAlD
Tetrabenazine—DRD2—Circadian rythm related genes—CHRNB2—nicotine dependence	0.000393	0.00444	CbGpPWpGaD
Tetrabenazine—DRD2—G alpha (i) signalling events—OPRM1—nicotine dependence	0.000354	0.00401	CbGpPWpGaD
Tetrabenazine—DRD2—midbrain—nicotine dependence	0.000349	0.0907	CbGeAlD
Tetrabenazine—DRD2—GPCRs, Class A Rhodopsin-like—OPRM1—nicotine dependence	0.000329	0.00372	CbGpPWpGaD
Tetrabenazine—DRD2—GPCR downstream signaling—TAS2R16—nicotine dependence	0.000288	0.00326	CbGpPWpGaD
Tetrabenazine—DRD2—Class A/1 (Rhodopsin-like receptors)—OPRM1—nicotine dependence	0.000282	0.00319	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling by GPCR—TAS2R16—nicotine dependence	0.000261	0.00296	CbGpPWpGaD
Tetrabenazine—DRD2—GPCR downstream signaling—FGD1—nicotine dependence	0.000226	0.00255	CbGpPWpGaD
Tetrabenazine—DRD2—brain—nicotine dependence	0.000219	0.057	CbGeAlD
Tetrabenazine—DRD2—GPCR ligand binding—OPRM1—nicotine dependence	0.000215	0.00243	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling by GPCR—FGD1—nicotine dependence	0.000205	0.00232	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—TAS2R16—nicotine dependence	0.000154	0.00175	CbGpPWpGaD
Tetrabenazine—CYP2D6—brain—nicotine dependence	0.000132	0.0343	CbGeAlD
Tetrabenazine—DRD2—GPCR downstream signaling—OPRM1—nicotine dependence	0.000121	0.00137	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—FGD1—nicotine dependence	0.000121	0.00137	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling by GPCR—OPRM1—nicotine dependence	0.00011	0.00125	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—AKR1B10—nicotine dependence	0.000107	0.00121	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—WASF2—nicotine dependence	7.53e-05	0.000853	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—WASF1—nicotine dependence	7.22e-05	0.000818	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—CYP2A7—nicotine dependence	6.94e-05	0.000785	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—OPRM1—nicotine dependence	6.5e-05	0.000736	CbGpPWpGaD
